COMPARISON OF RATES OF ACTIVE TUBERCULOSIS INFECTION IN THE PHASE 2 AND 3 CLINICAL TRIAL PROGRAMS FOR ANTI-IL12/23 AND ANTI-TNFS

Edward Jr; Sheldon Sloan; Paraneedharan Ramachandran; Zijiang Yang; Chun Guo; Christopher Gasink; Bruno Silva

doi:10.28952/s2359-2737.2017.02.1043

COMPARISON OF RATES OF ACTIVE TUBERCULOSIS INFECTION IN THE PHASE 2 AND 3 CLINICAL TRIAL PROGRAMS FOR ANTI-IL12/23 AND ANTI-TNFS

Arquivos Brasileiros de Cirurgia Digestiva Express ◽

10.28952/s2359-2737.2017.02.1043 ◽

2017 ◽

Vol 28 (Supl.5) ◽

pp. 1043-1043

Author(s):

Edward Jr ◽

Sheldon Sloan ◽

Paraneedharan Ramachandran ◽

Zijiang Yang ◽

Chun Guo ◽

...

Keyword(s):

Clinical Trial ◽

Active Tuberculosis ◽

Tuberculosis Infection ◽

Phase 2

Download Full-text

Comparison of Rates of Active Tuberculosis Infection in the Phase 2 and 3 Clinical Trial Programs for Anti-IL12/23 and Anti-TNFS

Gastroenterology ◽

10.1016/s0016-5085(17)32134-0 ◽

2017 ◽

Vol 152 (5) ◽

pp. S596 ◽

Cited By ~ 5

Author(s):

Edward V. Loftus ◽

Sheldon Sloan ◽

Paraneedharan Ramachandran ◽

Zijiang Yang ◽

Chun-Yuan Guo ◽

...

Keyword(s):

Clinical Trial ◽

Active Tuberculosis ◽

Tuberculosis Infection ◽

Phase 2

Download Full-text

Comparison of a Novel Tazarotene 0.045% Lotion to Tazarotene 0.1% Cream: Patient-Reported Outcomes from a Phase 2 Clinical Trial

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.3.supp.9 ◽

2019 ◽

Vol 3 ◽

pp. S9

Author(s):

Zoe Draelos ◽

Fran Cook-Bolden ◽

Lawrence Green ◽

Eric Guenin ◽

Gina Martin ◽

...

Keyword(s):

Clinical Trial ◽

Patient Reported Outcomes ◽

Phase 2 ◽

Patient Reported ◽

Phase 2 Clinical Trial

Abstract not available.

Download Full-text

Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Case Medical Research ◽

10.31525/ct1-nct04283669 ◽

2020 ◽

Author(s):

Keyword(s):

Clinical Trial ◽

Neurofibromatosis Type ◽

Neurofibromatosis Type 2 ◽

Vestibular Schwannomas ◽

Phase 2 ◽

Phase 2 Clinical Trial

Download Full-text

Faculty Opinions recommendation of Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1047842.497861 ◽

2006 ◽

Author(s):

David Sullivan

Keyword(s):

Clinical Trial ◽

Plasmodium Falciparum ◽

Combination Therapy ◽

Falciparum Malaria ◽

Plasmodium Falciparum Malaria ◽

Phase 2 ◽

Phase 2 Clinical Trial ◽

Uncomplicated Plasmodium Falciparum Malaria ◽

Randomized Phase 2

Download Full-text

Faculty Opinions recommendation of Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727784209.793552909 ◽

2018 ◽

Author(s):

Warren A Chow

Keyword(s):

Clinical Trial ◽

Macrophage Infiltration ◽

Phase 2 ◽

Pathway Activation ◽

Phase 2 Clinical Trial

Download Full-text

Faculty Opinions recommendation of Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1-Low/Negative Recurrent or Metastatic HNSCC: The Phase 2 CONDOR Randomized Clinical Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734352410.793553981 ◽

2018 ◽

Author(s):

Naomi Kiyota

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Phase 2 ◽

Safety And Efficacy

Download Full-text

Phase 2 Clinical Trial of Intraoral Grafting of Human Tissue-Engineered Oral Mucosa

10.21236/ada591622 ◽

2013 ◽

Author(s):

Stephen E. Feinberg

Keyword(s):

Clinical Trial ◽

Oral Mucosa ◽

Human Tissue ◽

Phase 2 ◽

Phase 2 Clinical Trial

Download Full-text

Re: Campochiaro et al.: The Port Delivery System with ranibizumab for neovascular age-related macular degeneration: results from the randomized phase 2 Ladder clinical trial (Ophthalmology. 2019;126:1141-1154)

Ophthalmology ◽

10.1016/j.ophtha.2019.06.019 ◽

2019 ◽

Vol 126 (11) ◽

pp. e87-e88 ◽

Cited By ~ 1

Author(s):

Ashish Sharma ◽

Nilesh Kumar ◽

Baruch D. Kuppermann ◽

Bandello Francesco

Keyword(s):

Clinical Trial ◽

Macular Degeneration ◽

Delivery System ◽

Age Related Macular Degeneration ◽

Phase 2 ◽

Age Related ◽

Randomized Phase 2

Download Full-text

A Descriptive Cost‐Analysis of MYX.1/MCRN003, a Phase 2 Clinical Trial Evaluating High‐dose Weekly Carfilzomib, Cyclophosphamide, and Dexamethasone in Relapsed and Refractory Multiple Myeloma

European Journal Of Haematology ◽

10.1111/ejh.13671 ◽

2021 ◽

Author(s):

Bethany E. Monteith ◽

Christopher P. Venner ◽

Matthew C. Cheung ◽

Joe Pater ◽

Lois Shepherd ◽

...

Keyword(s):

Clinical Trial ◽

Multiple Myeloma ◽

Cost Analysis ◽

High Dose ◽

Phase 2 ◽

Refractory Multiple Myeloma ◽

Phase 2 Clinical Trial

Download Full-text

Number Needed to Treat and Number Needed to Harm analysis of the zuranolone phase 2 clinical trial results in major depressive disorder

Journal of Affective Disorders ◽

10.1016/j.jad.2021.02.027 ◽

2021 ◽

Vol 285 ◽

pp. 112-119

Author(s):

Alix Arnaud ◽

Ellison Suthoff ◽

Katie Stenson ◽

Brian Werneburg ◽

Paul Hodgkins ◽

...

Keyword(s):

Clinical Trial ◽

Major Depressive Disorder ◽

Depressive Disorder ◽

Number Needed To Treat ◽

Phase 2 ◽

Major Depressive ◽

Phase 2 Clinical Trial ◽

Clinical Trial Results ◽

Number Needed To Harm

Download Full-text